• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔状况与髋部骨折患者颌骨坏死风险因素的关系。

Relationship between oral condition and risk factors for jaw osteonecrosis in patients with hip fractures.

机构信息

Department of Orthopedic Surgery, Kagawa Prefectural Central Hospital, Takamatsu, Kagawa, Japan.

Department of Oral and Maxillofacial Surgery, Kagawa Prefectural Central Hospital, Kagawa, Japan.

出版信息

J Med Invest. 2020;67(3.4):328-331. doi: 10.2152/jmi.67.328.

DOI:10.2152/jmi.67.328
PMID:33148910
Abstract

Purpose : Antiresorptive agents, such as bisphosphonates, are useful for the prevention of the recurrence of hip fractures. However, their administration has a risk of antiresorptive agent-related osteonecrosis of the jaw (ARONJ), and risk factors include poor oral hygiene. It is difficult for an orthopedic surgeon to examine a patient's oral condition thoroughly. This study evaluated the relationship between risk factors for ARONJ and intraoral findings in hip fracture patients. Materials and Methods : We evaluated 79 patients (average age of 82.2 years) with hip fracture surgery who underwent an oral assessment by dentists. The risk assessments of the intraoral findings were classified into four levels (levels 0-3), with levels 2 and 3 requiring dental treatment intervention. Data that could be extracted as risk factors of ARONJ were also examined. Results : Level 1 was found most frequently (54.4%), followed by level 0 (35.4%), level 2 (8.9%), level 3 (1.3%). The area under the receiver operating characteristic curve for the number of risk factors for the two groups (dental treatment intervention required and unnecessary) and oral findings were 0.732. When the cut-off value was set to two risk factors, the specificity and sensitivity was 53.5% and 87.5%. Conclusions : For hip fracture patients with a more than 2 risk factors, dental visits are recommended to prevent ARONJ. This is a useful evaluation method that can be used to screen for ONJ from data obtained from other risk factors, even if it is difficult to evaluate the oral condition in hospitals where dentists are absent. J. Med. Invest. 67 : 328-331, August, 2020.

摘要

目的

抗吸收剂,如双磷酸盐,可用于预防髋部骨折的复发。然而,它们的使用有抗吸收剂相关的下颌骨坏死(ARONJ)的风险,其危险因素包括口腔卫生差。骨科医生很难彻底检查患者的口腔状况。本研究评估了髋部骨折患者 ARONJ 的危险因素与口腔内发现之间的关系。

材料与方法

我们评估了 79 名接受髋部骨折手术的患者(平均年龄 82.2 岁),由牙医进行口腔评估。将口腔内发现的风险评估分为四个等级(0-3 级),2 级和 3 级需要进行牙科治疗干预。还检查了可作为 ARONJ 危险因素的数据。

结果

最常见的是 1 级(54.4%),其次是 0 级(35.4%),2 级(8.9%),3 级(1.3%)。两组(需要和不需要牙科治疗干预)和口腔发现的风险因素数量的受试者工作特征曲线下面积为 0.732。当截断值设定为两个危险因素时,特异性和敏感性分别为 53.5%和 87.5%。

结论

对于髋部骨折患者,如果存在超过 2 个危险因素,建议进行牙科就诊,以预防 ARONJ。这是一种有用的评估方法,即使在没有牙医的医院,也可以使用该方法从其他危险因素获得的数据中筛查 ONJ。

相似文献

1
Relationship between oral condition and risk factors for jaw osteonecrosis in patients with hip fractures.口腔状况与髋部骨折患者颌骨坏死风险因素的关系。
J Med Invest. 2020;67(3.4):328-331. doi: 10.2152/jmi.67.328.
2
Incidence and risk of antiresorptive agent-related osteonecrosis of the jaw (ARONJ) after tooth extraction in patients with autoimmune disease.自身免疫性疾病患者拔牙后抗吸收剂相关颌骨坏死(ARONJ)的发生率和风险。
J Bone Miner Metab. 2020 Jul;38(4):581-588. doi: 10.1007/s00774-020-01089-y. Epub 2020 Feb 19.
3
Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone.抗吸收剂相关颌骨骨坏死(ARONJ):骨骼中的命运转折。
Tohoku J Exp Med. 2019 Feb;247(2):75-86. doi: 10.1620/tjem.247.75.
4
Denosumab, an Alternative to Bisphosphonates but also Associated with Osteonecrosis of the Jaw--What is the Risk?地诺单抗,双膦酸盐的替代品但也与颌骨坏死相关——风险是什么?
Dent Update. 2015 Jun;42(5):436-8, 440. doi: 10.12968/denu.2015.42.5.436.
5
CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.抗吸收剂相关性颌骨坏死/药物相关性颌骨坏死的 CT 影像学特征。
Dentomaxillofac Radiol. 2018 May;47(4):20170323. doi: 10.1259/dmfr.20170323. Epub 2018 Feb 13.
6
Antiresorptive agent-related osteonecrosis of the jaw in osteoporosis patients from Asian countries.亚洲国家骨质疏松症患者中抗吸收剂相关的颌骨坏死
Osteoporos Sarcopenia. 2017 Jun;3(2):64-74. doi: 10.1016/j.afos.2017.03.001. Epub 2017 Mar 21.
7
Single-center analysis of antiresorptive agent-related osteonecrosis of the jaw in lung cancer patients.单中心分析肺癌患者抗吸收剂相关性颌骨坏死。
Asia Pac J Clin Oncol. 2020 Dec;16(6):380-384. doi: 10.1111/ajco.13395. Epub 2020 Sep 7.
8
Osteonecrosis of the jaw in patients transitioning from bisphosphonates to denosumab treatment for osteoporosis.骨质疏松症患者从双膦酸盐类药物转换为地诺单抗治疗过程中的颌骨骨坏死。
Odontology. 2018 Oct;106(4):469-480. doi: 10.1007/s10266-018-0362-5. Epub 2018 Apr 30.
9
Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw.抗吸收剂相关颌骨坏死:日本颌骨坏死联合委员会2017年立场文件
J Bone Miner Metab. 2017 Jan;35(1):6-19. doi: 10.1007/s00774-016-0810-7. Epub 2016 Dec 29.
10
Development of Antiresorptive Agent-Related Osteonecrosis of the Jaw After Dental Implant Removal: A Case Report.牙种植体拔除后抗吸收剂相关颌骨坏死的发生:一例报告
J Oral Implantol. 2018 Oct;44(5):359-364. doi: 10.1563/aaid-joi-D-18-00032. Epub 2018 Jun 5.

引用本文的文献

1
Potential Relationship between Poor Oral Hygiene and MRONJ: An Observational Retrospective Study.口腔卫生不良与 MRONJ 之间的潜在关系:一项观察性回顾性研究。
Int J Environ Res Public Health. 2023 Apr 5;20(7):5402. doi: 10.3390/ijerph20075402.